Batch 001 - Live Allocation
3/100 SoldNext Release: Aug 2026
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -

§ Legal

Refund & Replacement Policy

Status - interim
Interim policy. Vivre Labs is operating in a pre-launch state. This page consolidates the refund commitments already made elsewhere on the Platform (the testing repository, the checkout flow, and the reservation terms) into one place. The full, counsel-certified, market-specific policy will replace this document at clinical launch.
Effective: at clinical launch · Last updated: May 2026

1. A lot that fails testing is never dispensed

Every lot Vivre allocates is independently tested before release (see the Testing & Certificates page). If a lot fails testing, it is not dispensed, and anyone who ordered from that lot is refunded in full. Results are published either way - the testing page shows what was found, including a lot that came in under its labelled mass.

2. A protocol your physician declines is refunded in full

Payment reserves your allocation and locks your Batch 001 rate - it does not authorize dispensing. Dispensing follows your physician consultation. Anything your physician declines at that consultation is refunded in full.

3. Reservation deposits

A reservation deposit is applied to your order once it proceeds, and is refundable per these terms if it does not. For crypto deposits specifically: funds convert to Vivre platform credit by default rather than an on-chain refund, to avoid gas fees making a small refund uneconomic; an on-chain refund to your wallet is available on request, gas fees permitting.

4. What this page does not yet cover

A specific refund timeframe, the process for a product damaged or lost in transit, and a like-for-like replacement policy are not yet published. These will be added once finalized - this page will not claim a commitment the Platform has not actually made.

5. Contact

For a refund request or a question about an order: use the contact options on the Platform, or your Telegram-linked account if you have one. Legal questions about this policy: legal@vivre.[domain].

This document is the interim, pre-launch version. The full, counsel-certified, market-specific versions for Malaysia, Indonesia, and Thailand are being prepared with named local counsel and will replace this document at clinical launch. The operating commitments described - supervised-only clinical care, the data architecture, the non-DTC operating boundary - reflect Vivre\'s deliberate design choices and are not expected to materially change in the final versions.
VL
Vivre Labs
Institutional Longevity

Clinical optimization through institutional medicine. All protocols verified and lot-tested, MSO-administered, hospital-integrated.

V-Series

Peptides

Metabolic
Repair & Aesthetic
Neurological
Growth & Hormonal
Longevity & Immune
Sexual Health

Navigate

Verification

DEMO SITE - PRESENTATION PURPOSES ONLY. All protocols verified and lot-tested, dispensed after comprehensive medical evaluation. Compounds sourced from registered cGMP compounding pharmacies. Individual results vary. MSO structures and revenue models are illustrative for partner conversations. Regulatory outcomes reference publicly disclosed FDA processes and are anticipated but not guaranteed.

© 2026 Vivre Labs. All rights reserved.

cGMPLot-TestedDemo

Demonstration prototype - not a live service